Results 121 to 130 of about 8,831,211 (337)

Consumer Price Indexes in Nine Countries, Percent Change From Same Period of Previous Year, 1990-2004 [PDF]

open access: yes, 2004
Special Reports and Statistics Comparative Statisticsconsumerpricenine.pdf: 60 downloads, before Oct.
Bureau of Labor Statistics
core   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

open access: yesMolecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero   +8 more
wiley   +1 more source

Auto Dealers are Fewer, Bigger, and Employ More Workers [PDF]

open access: yes, 1999
[Excerpt] New and used car dealerships are a fiercely competitive, cyclically sensitive segment of retail trade, but they show diverging trends in their number and in employment.
Bureau of Labor Statistics
core   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

open access: yesMolecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou   +5 more
wiley   +1 more source

1981 Statistics

open access: yes, 1981
1981 Men\u27s Cross Country Statistics, George Fox ...
George Fox University Archives
core   +2 more sources

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

An Edgeworth expansion for symmetric statistics [PDF]

open access: bronze, 1997
V. Bentkus   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy